International Journal of Dentistry

Volume 2013 (2013), Article ID 587279, 6 pages

http://dx.doi.org/10.1155/2013/587279

Review Article

Mixed Red-Complex Bacterial Infection in Periodontitis

N. Suzuki,¹ M. Yoneda,² and T. Hirofuji¹

¹Section of General Dentistry, Department of General Dentistry, Fukuoka Dental College, 2-15-1 Tamura, Sawara-ku, Fukuoka 814-0193, Japan

²Center for Oral Diseases, 3-2-1 Hakataekimae, Hakata-ku, Fukuoka 812-0011, Japan

Received 20 December 2012; Accepted 11 February 2013

Academic Editor: Tuula Salo

Copyright © 2013 N. Suzuki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

The red complex, which includes Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia (formerly Bacteroides forsythus), are recognized as the most important pathogens in adult periodontal disease. These bacteria are usually found together in periodontal pockets, suggesting that they may cause destruction of the periodontal tissue in a cooperative manner. This article discusses the interspecies pathogenic interactions within the red complex.

1. Introduction

Periodontal diseases are polymicrobial immune-inflammatory infectious diseases that can lead to the destruction of periodontal ligaments and adjacent supportive alveolar bone. The subgingival plaque contains more than 700 bacterial species, and some of these microorganisms have been shown to be responsible for initiation/progression of periodontal diseases [1, 2]. The red complex, which includes Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia (formerly Bacteroides forsythus), encompasses the most important pathogens in adult periodontal disease [3]. Additionally, Fusobacterium nucleatum, Prevotella species, Eikenella corrodens, Peptostreptococcus micros, and Campylobacter rectus are increased in deep periodontal pockets and are implicated as possible periodontopathogens [1–4]. These bacteria are not usually found alone, but in combination in the periodontal pockets, suggesting that some bacteria may cause destruction of the periodontal tissue in a cooperative manner [5]. Studies using animal models have reported the synergistic pathogenicity of mixed infections with P. gingivalis-T. denticola, P. gingivalis-F. nucleatum, P. gingivalis-T. forsythia, P. gingivalis-Aggregatibacter actinomycetemcomitans, F. nucleatum-T. forsythia, and P. gingivalis-T. denticola-T. forsythia [6–11]. Furthermore, coaggregation, nutrient effects, and modulation of virulence factors by periodontopathogens or by interspecies interactions between periodontopathogenic and nonpathogenic organisms have been reported to contribute to oral microbial pathogenesis [12]. This paper focuses on interspecies pathogenic interactions within the red complex, in particular the combinations of P. gingivalis-T. forsythia, P. gingivalis-T. denticola, and P. gingivalis-T. forsythia-T. denticola. Potential therapies using normal inhabitants of the oral microbiota that have an antagonistic relationship with the red complex are discussed.

2. P. gingivalis and T. forsythia

P. gingivalis possesses many virulence factors, such as fimbriae, lipopolysaccharides, and proteases [13–15]. The arg-gingipain (Rgp) and lys-gingipain (Kgp) cysteine proteinases are important for the virulence of P. gingivalis as they elicit dysfunction of inflammatory and immune responses and can degrade various connective tissue proteins [16, 17]. Rgp is encoded by two separate genes (rgpA and rgpB), whereas Kgp is encoded by a single gene (kgp) [18]. In a murine abscess model, rgpA and rgpB double and kgp single-mutants induced smaller abscesses than did the wild type, and the rgpA-rgpB-kgp triple (gingipain-null) mutant showed negligible lesion formation [19]. These findings indicate that gingipains play an important role in abscess formation in mice.

Compared to the abscess formation induced by monoinfection with each bacterium in the abovedescribed murine model, mixed infection with wild-type P. gingivalis ATCC 33277 and T. forsythia ATCC 43037 showed a synergistic effect on abscess formation [19]. On the other hand, mixed infection with P. gingivalis mutants devoid of gingipain (rgpA rgpB, kgp, and rgpA rgpB kgp) with T. forsythia showed only just an additive effect on abscess formation. These findings suggest that the gingipains of P. gingivalis play an important role in the pathological synergism between P. gingivalis and T. forsythia. A combination of T. forsythia strains isolated from periodontitis patients and P. gingivalis also showed synergistic pathogenesis in a rabbit abscess model [20]. The researchers found 100% abscess formation in rabbits with mixed infection using P. gingivalis and T. forsythia but 0% in rabbits with monoinfection with each bacterium. Recently, Verma et al. [21] injected P. gingivalis FDC 381 and T. forsythia ATCC 43037 into the oral cavity of rats and evaluated the synergistic effect of mixed infection on periodontal disease. Mixed colonization by P. gingivalis and T. forsythia in the rat oral cavity was confirmed by polymerase chain reaction (PCR). The induction of moderate periodontal inflammation and pronounced apical migration of junctional epithelium, generation of a specific immunoglobulin G (IgG) antibody response, and stimulation of both Th1- and Th2-like immune responses as reflected by the serum IgG subclass profiles were evident. Mixed infection with P. gingivalis and T. forsythia resulted in a significant increase in interproximal alveolar bone resorption compared to that in rats infected with a single bacterial strain and controls, but there was no synergy between the bacteria [21]. The researchers indicated that the virulence of P. gingivalis and T. forsythia mixed infection resulted from the immune-inflammatory responses and the lack of humoral immune protection during periodontitis in rats.

Humoral immune responses were induced by P. gingivalis in the murine abscess model [22]. Mice that were first infected with a wild-type strain and subsequently reinfected with the same wild-type strain showed significantly smaller lesions than control mice that were mock-infected with medium only and then re-infected with the wild-type strain. Yoneda et al. [23] assessed the serum IgG antibody response in a murine abscess model after mixed infection with various levels of P. gingivalis ATCC 33277 or T. forsythia ATCC 43037 whole bacteria cell antigens. After mixed infection, IgG antibody responses to P. gingivalis increased in proportion to the level of T. forsythia injected. In contrast, IgG antibody responses to T. forsythia did not correlate with the level of P. gingivalis injected. Reasons for this difference may be that P. gingivalis and T. forsythia induced different antibody responses after mixed infection in mice; alternatively, these bacteria may exhibit different interactions in terms of growth at the injected sites.

T. forsythia, which is a fastidious anaerobic Gram-negative rod, is frequently isolated together with P. gingivalis, especially from the active state of periodontitis [24–27]. It is well known that the growth of T. forsythia is accelerated on blood agar when cocultivated with P. gingivalis or F. nucleatum, suggesting that a form of symbiosis occurs with respect to nutrition [28]. Furthermore, the growth-promoting factors appear to be proteinaceous in nature. Sonicated cell extracts of T. forsythia ATCC 43037 stimulate growth of P. gingivalis ATCC 33277 in nutrition-decreased medium in a dose-dependent manner [29], whereas the cell extract of T. forsythia had no stimulatory effect on the growth of the rgpA rgpB kgp triple (gingipain-null) mutant of P. gingivalis. These results suggest that gingipains of P. gingivalis play an important role in the digestion or uptake of the growth-promoting factor derived from T. forsythia. The growth-promoting interaction between P. gingivalis and T. forsythia may be partly related to synergistic virulence in a murine abscess model.

T. forsythia is a member of the polymicrobial flora that invades buccal epithelial cells taken directly from the mouth [30]. Epithelial cell invasion by periodontopathogens is considered to be an important virulence mechanism for evasion of the host defense responses and for forming reservoirs important in recurrent infections. T. forsythia possesses some putative virulence factors, such as a trypsin-like protease, a sialidase, hemagglutinin, components of the bacterial S-layer, and a cell surface-associated and secreted protein (BspA) [31]. BspA has been recognized as a virulence factor important for alveolar bone loss in mice [31]. Inagaki et al. [32] investigated the epithelial cell adherence and invasion abilities of T. forsythia and reported that these are dependent on BspA. Additionally, they found that P. gingivalis FDC 381 or its outer membrane vesicles enhance the attachment and invasion of T. forsythia ATCC 43037 to epithelial cells.

3. P. gingivalis and T. denticola

T. denticola, a small oral spirochete, is frequently found with P. gingivalis in progressing periodontitis lesions [1, 33–35]. T. denticola is located within the surface layers of the subgingival plaque, whereas P. gingivalis is observed predominantly beneath the spirochete layer [33]; a symbiotic nutrient utilization relationship between these two periodontopathogens has been shown in vitro [36]. The growth-stimulating factors produced by P. gingivalis ATCC 33277 and T. denticola ATCC 35405 have been identified as isobutyric acid and succinic acid, respectively [36].

Biofilm formation is also an important step in the etiology of periodontal diseases. P. gingivalis, but not T. denticola strains, formed biofilms in vitro [37]. Coculture of P. gingivalis FDC 381 and T. denticola ATCC 35405 induced synergistic biofilm formation and coaggregation. Confocal microscopy demonstrated that P. gingivalis attaches to the substratum first as the primary colonizer followed by coaggregation with T. denticola to form a mixed biofilm [38]. The T. denticola flagellar mutant and cytoplasmic filament mutant exhibit significantly reduced biofilm formation with P. gingivalis. Similarly, the P. gingivalis gingipain mutant and major fimbriae mutant exhibited significantly reduced biofilm formation with T. denticola [38]. Using two-dimensional electrophoresis followed by a ligand overlay assay with P. gingivalis fimbriae, Hashimoto et al. [39] determined that dentilisin, a chymotrypsin-like proteinase of T. denticola,  was the P. gingivalis fimbriae-binding protein. These results support the hypothesis that these two organisms assist each other’s survival in subgingival sulcus and explain why they are frequently isolated together from subgingival plaque.

Synergistic virulence of mixed P. gingivalis and T. denticola infection has been assessed in several animal lesion models. Using a murine abscess model, one group reported that high doses of P. gingivalis W50 ( cells per dose) together with T. denticola ATCC 35404 ( or cells per dose) had no effect on the formation and size of the spreading lesion caused by P. gingivalis [40]. However, at low P. gingivalis doses ( cells), addition of T. denticola ( cells) significantly enhanced the virulence of P. gingivalis compared with monoinfection [40]. Investigation of the synergistic virulence of P. gingivalis and T. denticola using a murine experimental model of periodontitis found that a 1 : 1 ratio of P. gingivalis W50 and T. denticola ATCC 35405 coinoculum at or total bacterial cells induced the same level of bone loss as four doses of   P. gingivalis [41]. Coinoculation induced strong P. gingivalis-specific T cell proliferative and interferon-γ (IFN-γ) cytokine responses and induced a strong T. denticola-specific IFN-γ cytokine response. Another study using a rat model of periodontal disease reported that a mixed P. gingivalis FDC 381 ( cells) and T. denticola ATCC 35404 ( cells) infection produced significantly more interproximal and horizontal alveolar bone loss compared to monoinfections ( cells); however, there was no synergy between P. gingivalis and T. denticola [42]. Furthermore, colonization of these bacteria was observed in the rat oral cavity during 7 weeks of periodontal disease, resulting in the generation of a specific serum IgG antibody response that reflected oral infection and the induction of an inflammatory response consistent with the established characteristics of periodontitis. These results suggest that P. gingivalis and T. denticola act synergistically (with no synergy between the bacteria) to stimulate the host immune response and to induce alveolar bone loss in a rat model of periodontitis [42].

4. P. gingivalis, T. forsythia, and T. denticola

Epithelial cells and macrophages play a major role in the host response to periodontopathogens, and secretion of inflammatory mediators and matrix metalloproteinases (MMPs) by these host cells contribute to periodontal tissue destruction. Bodet et al. [43] investigated the inflammatory response of an in vitro macrophage/epithelial cell coculture model following mono- or mixed infections with whole bacterial cells of the red-complex and their lipopolysaccharide (LPS). Mono- or mixed infections of the coculture model induced the secretion of interleukin-1 beta (IL-1), IL-6, IL-8, prostaglandin E₂ (PGE₂), and MMP-9. All LPS mono- or mixed infections induced an increase in chemokine, MMP-9, and PGE₂ production. Compared to mono-infections with individual bacterial species, no synergistic effects on cytokine, PGE₂, or MMP-9 production by the bacterial mixtures tested were observed. P. gingivalis and T. forsythia induced the secretion of RANTES (regulated and normal T cell expressed and secreted), whereas T. denticola alone or in combination with P. gingivalis resulted in a significant decrease in RANTES levels. RANTES degradation by mono- or mixed infections with red-complex bacteria resulted in massive proteolytic degradation of RANTES by T. denticola. The ability of periodontopathogens to degrade cytokines and chemokines in vivo may play an important role in their pathogenicity by disrupting the host inflammatory response.

Recently, polymicrobial infection with P. gingivalis, T. denticola, and T. forsythia in a rat model of periodontal disease was investigated [44]. A  cell mixture (1 mL) containing an equal number of cells of each bacterium was injected into the rat oral cavity. PCR of the bacterial DNA in the oral sample revealed that polymicrobial infection enhanced colonization by P. gingivalis, T. denticola, and T. forsythia compared to their levels in monomicrobial infections. Oral infection of rats with a polymicrobial consortium comprising P. gingivalis, T. denticola, and T. forsythia induced significant increases in maxillary and mandibular alveolar bone resorption compared to those resulting from any of the monomicrobial infections (). The levels of serum IgG against all of the bacteria in the polymicrobial infection were lower than the respective levels induced by monomicrobial infections. This suggested that the host response to the polymicrobial infection was altered, resulting in enhanced evasion of protective immune responses by the bacterial consortium.

5. Future Directions of Periodontitis Therapy

Most therapeutic modalities for treatment of periodontitis aim to remove pathogens and kill all bacteria in the periodontal pocket. Understanding the effect of interbacterial interactions on the pathogenesis of periodontitis may facilitate development of novel treatment modalities, such as the inhibition of adherence using antagonists, passive immunization, replacement therapy, regulation of levels of nonpathogenic bacteria to modulate virulence, probiotics, and interference with signaling mechanisms [12]. The disruption of the harmonic relationship between the host and commensal microorganisms is considered to be an important factor for the development of oral pathologies. The microbiota composition of healthy and periodontitis patients differs [45–47]. Here, we discuss the significance of interbacterial antagonism for maintenance and recovery of a healthy oral microbiota. Antagonistic bacteria present a substantial barrier to colonization by exogenous and opportunistic endogenous pathogens. Moreover, antagonistic bacteria have the potential for probiotic action, which may protect against periodontitis.

Studies have identified organisms antagonistic to periodontopathogens. With regard to the red complex, Staphylococcus aureus and Streptococcus mutans isolates inhibited the growth of T. denticola and P. gingivalis [48]. S. aureus strains produced a bacteriocin-like inhibitory substance, whereas the inhibitory effect of S. mutans was related to the production of lactic acid. S. sanguinis, S. cristatus, S. salivarius, S. mitis, Actinomyces naeslundii, and Haemophilus parainfluenzae inhibited the adhesion of standard P. gingivalis strains in vitro [49]. S. cristatus arginine deiminase repressed FimA, a major subunit protein of the long fimbriae, and inhibited biofilm formation by P. gingivalis [50].

Other studies have identified organisms with probiotic potential against periodontopathogens. An analysis of the ability of clinical isolates from healthy and periodontitis patients to inhibit the growth of periodontopathogens showed that the number of isolates from healthy volunteers that inhibited either P. gingivalis or P. intermedia was significantly higher than that from diseased patients [51]. These isolated growth-inhibiting strains included some viridans group Streptococcus, Actinomyces, and Bifidobacterium strains. Compared to these isolates, commercial dietary probiotics showed stronger inhibition of the periodontopathogens. In a study that compared oral lactobacilli from patients with chronic periodontitis and periodontally healthy subjects, the most prevalent species in healthy subjects were Lactobacillus gasseri and L. fermentum, whereas the most prevalent species in subjects with periodontitis was L. plantarum [52]. Furthermore, the greatest antimicrobial activities were associated with L. paracasei, L. plantarum, L. rhamnosus, and L. salivarius. The international guidelines for the evaluation of probiotics confirm that these four organisms exhibit both high antimicrobial activity and high tolerance to environmental stress [53].

Some oral bacteria possess the potential for antagonism towards periodontopathogens, which highlights the therapeutic potential of stimulation of oral health using beneficial effector strains. Most evidence indicates that probiotics in the gut do not populate the gastrointestinal microbiota permanently, and they disappear from feces soon after cessation of probiotic ingestion [54]. Similarly, altering the composition of established oral plaque microbial communities is difficult [55]. Probiotic bacteria used in the human oral cavity include Bifidobacterium and Lactobacillus species, and most of them were not derived from the oral cavity [56]. L. reuteri and L. salivarius colonized the oral cavity of patients; however, the study was of only 2 weeks duration [57–59]. Another study reported that oral administration of L. salivarius decreased the proportion of L. salivarius in saliva during the 4- and 8-week intervention periods, although the sampling and analysis methods differed [60]. Organisms antagonistic to periodontopathogens that are derived from typical representatives of the oral microbiota and have probiotic potential may overcome the weaknesses associated with exogenous probiotic bacteria.

References

B. J. Paster, I. Olsen, J. A. Aas, and F. E. Dewhirst, “The breadth of bacterial diversity in the human periodontal pocket and other oral sites,” Periodontology 2000, vol. 42, no. 1, pp. 80–87, 2006.

A. P. V. Colombo, S. K. Boches, S. L. Cotton et al., “Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray,” Journal of Periodontology, vol. 80, no. 9, pp. 1421–1432, 2009.

S. S. Socransky, A. D. Haffajee, M. A. Cugini, C. Smith, and R. L. Kent Jr., “Microbial complexes in subgingival plaque,” Journal of Clinical Periodontology, vol. 25, no. 2, pp. 134–144, 1998.

P. E. Kolenbrander, “Oral microbial communities: biofilms, interactions, and genetic systems,” Annual Review of Microbiology, vol. 54, pp. 413–437, 2000.

R. P. Darveau, A. Tanner, and R. C. Page, “The microbial challenge in periodontitis,” Periodontology 2000, vol. 1997, no. 14, pp. 12–32, 1997.

J. L. Ebersole, F. Feuille, L. Kesavalu, and S. C. Holt, “Host modulation of tissue destruction caused by periodontopathogens: effects on a mixed microbial infection composed of Porphyromonas gingivalis and Fusobacterium nucleatum,” Microbial Pathogenesis, vol. 23, no. 1, pp. 23–32, 1997.

L. Kesavalu, S. C. Holt, and J. L. Ebersole, “Virulence of a polymicrobic complex, Treponema denticola and Porphyromonas gingivalis, in a murine model,” Oral Microbiology and Immunology, vol. 13, no. 6, pp. 373–377, 1998.

P. B. Chen, L. B. Davern, J. Katz, J. H. Eldridge, and S. M. Michalek, “Host responses induced by co-infection with Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in a murine model,” Oral Microbiology and Immunology, vol. 11, no. 4, pp. 274–281, 1996.

T. Takemoto, H. Kurihara, and G. Dahlen, “Characterization of Bacteroides forsythus isolates,” Journal of Clinical Microbiology, vol. 35, no. 6, pp. 1378–1381, 1997.

L. Kesavalu, S. Sathishkumar, V. Bakthavatchalu et al., “Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease,” Infection and Immunity, vol. 75, no. 4, pp. 1704–1712, 2007.

R. P. Settem, A. T. El-Hassan, K. Honma, G. P. Stafford, and A. Sharma, “Fusobacterium nucleatum and Tannerella forsythia induce synergistic alveolar bone less in a mouse periodontitis model,” Infection and Immunity, vol. 80, pp. 2436–2443, 2012.

H. K. Kuramitsu, X. He, R. Lux, M. H. Anderson, and W. Shi, “Interspecies interactions within oral microbial communities,” Microbiology and Molecular Biology Reviews, vol. 71, no. 4, pp. 653–670, 2007.

F. Yoshimura, “Molecular biology of P. gingivalis fimbriae,” in Biology of the Species Porphyromonas Gingivalis, H. N. Shah, D. Mayrand, and R. J. Genco, Eds., pp. 321–338, CRC Press, Boca Raton, Fla, USA, 1993.

M. Wilson, “Biological activities of lipopolysaccharide and endotoxin,” in Biology of the Species Porphyromonas Gingivalis, H. N. Shah, D. Mayrand, and R. J. Genco, Eds., pp. 171–197, CRC Press, Boca Raton, Fla, USA, 1993.

D. Grenier and D. Mayrand, “Proteinases,” in Biology of the Species Porphyromonas Gingivalis, H. N. Shah, D. Mayrand, and R. J. Genco, Eds., pp. 227–243, CRC Press, Boca Raton, Fla, USA, 1993.

M. Yoneda, K. Maeda, and M. Aono, “Suppression of bactericidal activity of human polymorphonuclear leukocytes by Bacteroides gingivalis,” Infection and Immunity, vol. 58, no. 2, pp. 406–411, 1990.

J. Potempa, R. Pike, and J. Travis, “The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain,” Infection and Immunity, vol. 63, no. 4, pp. 1176–1182, 1995.

H. K. Kuramitsu, “Proteases of Porphyromonas gingivalis: what don't they do?” Oral Microbiology and Immunology, vol. 13, no. 5, pp. 263–270, 1998.

M. Yoneda, T. Hirofuji, H. Anan et al., “Mixed infection of Porphyromonas gingivalis and Bacteroides forsythus in a murine abscess model: involvement of gingipains in a synergistic effect,” Journal of Periodontal Research, vol. 36, no. 4, pp. 237–243, 2001.

T. Takemoto, H. Kurihara, and G. Dahlen, “Characterization of Bacteroides forsythus isolates,” Journal of Clinical Microbiology, vol. 35, no. 6, pp. 1378–1381, 1997.

R. K. Verma, I. Bhattacharyya, A. Sevilla et al., “Virulence of major periodontal pathogens and lack of humoral immune protection in a rat model of periodontal disease,” Oral Diseases, vol. 16, no. 7, pp. 686–695, 2010.

M. Yoneda, T. Hirofuji, N. Motooka et al., “Antibody responses to Porphyromonas gingivalis infection in a murine abscess model—involvement of gingipains and responses to re-infection,” Journal of Periodontal Research, vol. 38, no. 6, pp. 551–556, 2003.

M. Yoneda, N. Motooka, H. Anan et al., “Antibody responses after mixed infection with Porphyromonas gingivalis and Tannerella forsythia in a murine abscess model,” Japanese Journal of Conservative Dentistry, vol. 4, pp. 549–555, 2004.

J. L. Dzink, S. S. Socransky, and A. D. Haffejee, “The predominant cultivable microbiota of active and inactive lesions of destructive periodontal diseases,” Journal of Clinical Periodontology, vol. 15, no. 5, pp. 316–323, 1988.

C. H. Lai, M. A. Listgarten, M. Shirakawa, and J. Slots, “Bacteroides forsythus in adult gingivitis and periodontitis,” Oral Microbiology and Immunology, vol. 2, no. 4, pp. 152–157, 1987.

S. G. Grossi, J. J. Zambon, A. W. Ho et al., “Assessment of risk for periodontal disease. I. Risk indicators for attachment loss,” Journal of Periodontology, vol. 65, no. 3, pp. 260–267, 1994.

S. G. Grossi, R. J. Genco, E. E. Machtei et al., “Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss,” Journal of Periodontology, vol. 66, no. 1, pp. 23–29, 1995.

J. L. Dzink, C. M. Smith, and S. S. Socransky, “Development of a broth medium for Bacteroides forsythus,” Journal of Clinical Microbiology, vol. 25, no. 5, article 925, 1987.

M. Yoneda, T. Yoshikane, N. Motooka et al., “Stimulation of growth of Porphyromonas gingivalis by cell extracts from Tannerella forsythia,” Journal of Periodontal Research, vol. 40, no. 2, pp. 105–109, 2005.

J. D. Rudney, R. Chen, and G. J. Sedgewick, “Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythensis are components of a polymicrobial intracellular flora within human buccal cells,” Journal of Dental Research, vol. 84, no. 1, pp. 59–63, 2005.

A. Sharma, S. Inagaki, K. Honma, C. Sfintescu, P. J. Baker, and R. T. Evans, “Tannerella forsythia-induced alveolar bone loss in mice involves leucine-rich-repeat BspA protein,” Journal of Dental Research, vol. 84, no. 5, pp. 462–467, 2005.

S. Inagaki, S. Onishi, H. K. Kuramitsu, and A. Sharma, “Porphyromonas gingivalis vesicles enhance attachment, and the leucine-rich repeat BspA protein is required for invasion of epithelial cells by “Tannerella forsythia”,” Infection and Immunity, vol. 74, no. 9, pp. 5023–5028, 2006.

T. Kigure, A. Saito, K. Seida, S. Yamada, K. Ishihara, and K. Okuda, “Distribution of Porphyromonas gingivalis and Treponema denticola in human subgingival plaque at different periodontal pocket depths examined by immunohistochemical methods,” Journal of Periodontal Research, vol. 30, no. 5, pp. 332–341, 1995.

G. R. Riviere, K. S. Smith, N. Carranza et al., “Associations between Porphyromonas gingivalis and oral treponemes in subgingival plaque,” Oral Microbiology and Immunology, vol. 11, no. 3, pp. 150–155, 1996.

L. G. Simonson, K. T. McMahon, D. W. Childers, and H. E. Morton, “Bacterial synergy of Treponema denticola and Porphyromonas gingivalis in a multinational population,” Oral Microbiology and Immunology, vol. 7, no. 2, pp. 111–112, 1992.

D. Grenier, “Nutritional interactions between two suspected periodontopathogens, Treponema denticola and Porphyromonas gingivalis,” Infection and Immunity, vol. 60, no. 12, pp. 5298–5301, 1992.

H. K. Kuramitsu, W. Chen, and A. Ikegami, “Biofilm formation by the periodontopathic bacteria Treponema denticola and Porphyromonas gingivalis,” Journal of Periodontology, vol. 76, no. 11, pp. 2047–2051, 2005.

M. Yamada, A. Ikegami, and H. K. Kuramitsu, “Synergistic biofilm formation by Treponema denticola and Porphyromonas gingivalis,” FEMS Microbiology Letters, vol. 250, no. 2, pp. 271–277, 2005.

M. Hashimoto, S. Ogawa, Y. Asai, Y. Takai, and T. Ogawa, “Binding of Porphyromonas gingivalis fimbriae to Treponema denticola dentilisin,” FEMS Microbiology Letters, vol. 226, no. 2, pp. 267–271, 2003.

L. Kesavalu, S. C. Holt, and J. L. Ebersole, “Virulence of a polymicrobic complex, Treponema denticola and Porphyromonas gingivalis, in a murine model,” Oral Microbiology and Immunology, vol. 13, no. 6, pp. 373–377, 1998.

R. K. H. Orth, N. M. O'Brien-Simpson, S. G. Dashper, and E. C. Reynolds, “Synergistic virulence of Porphyromonas gingivalis and Treponema denticola in a murine periodontitis model,” Molecular Oral Microbiology, vol. 26, no. 4, pp. 229–240, 2011.

R. K. Verma, S. Rajapakse, A. Meka et al., “Porphyromonas gingivalis and Treponema denticola mixed microbial infection in a rat model of periodontal disease,” Interdisciplinary Perspectives on Infectious Diseases, vol. 2010, Article ID 605125, 2010.

C. Bodet, F. Chandad, and D. Grenier, “Inflammatory responses of a macrophage/epithelial cell co-culture model to mono and mixed infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia,” Microbes and Infection, vol. 8, no. 1, pp. 27–35, 2006.

L. Kesavalu, S. Sathishkumar, V. Bakthavatchalu et al., “Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease,” Infection and Immunity, vol. 75, no. 4, pp. 1704–1712, 2007.

C. S. Stingu, K. Eschrich, A. C. Rodloff, R. Schaumann, and H. Jentsch, “Periodontitis is associated with a loss of colonization by Streptococcus sanguinis,” Journal of Medical Microbiology, vol. 57, no. 4, pp. 495–499, 2008.

J. D. Hillman, S. S. Socransky, and M. Shivers, “The relationships between streptococcal species and periodontopathic bacteria in human dental plaque,” Archives of Oral Biology, vol. 30, no. 11-12, pp. 791–795, 1985.

J. D. Hillman and S. S. Socransky, “Bacterial interference in the oral ecology of Actinobacillus actinomycetemcomitans and its relationship to human periodontosis,” Archives of Oral Biology, vol. 27, no. 1, pp. 75–77, 1982.

D. Grenier, “Antagonistic effect of oral bacteria towards Treponema denticola,” Journal of Clinical Microbiology, vol. 34, no. 5, pp. 1249–1252, 1996.

C. G. van Hoogmoed, G. I. Geertsema-Doornbusch, W. Teughels, M. Quirynen, H. J. Busscher, and H. C. Van Der Mei, “Reduction of periodontal pathogens adhesion by antagonistic strains,” Oral Microbiology and Immunology, vol. 23, no. 1, pp. 43–48, 2008.

J. Wu and H. Xie, “Role of arginine deiminase of Streptococcus cristatus in Porphyromonas gingivalis colonization,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 11, pp. 4694–4698, 2010.

M. van Essche, G. Loozen, C. Godts et al., “Bacterial antagonism against periodontopathogens,” Journal of Periodontology, vol. 16, 2012.

P. Kõll-Klais, R. Mändar, E. Leibur, H. Marcotte, L. Hammarström, and M. Mikelsaar, “Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity,” Oral Microbiology and Immunology, vol. 20, no. 6, pp. 354–361, 2005.

P. Kõll, R. Mändar, H. Marcotte, E. Leibur, M. Mikelsaar, and L. Hammarström, “Characterization of oral lactobacilli as potential probiotics for oral health,” Oral Microbiology and Immunology, vol. 23, no. 2, pp. 139–147, 2008.

D. A. Devine and P. D. Marsh, “Prospects for the development of probiotics and prebiotics for oral applications,” Journal of Oral Microbiology, vol. 1, pp. 1–11, 2009.

M. Kilian, E. V. G. Frandsen, D. Haubek, and K. Poulsen, “The etiology of periodontal disease revisited by population genetic analysis,” Periodontology 2000, vol. 42, no. 1, pp. 158–179, 2006.

J. H. Meurman and I. Stamatova, “Probiotics: contributions to oral health,” Oral Diseases, vol. 13, no. 5, pp. 443–451, 2007.

P. Krasse, B. Carlsson, C. Dahl, A. Paulsson, A. Nilsson, and G. Sinkiewicz, “Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri,” Swedish Dental Journal, vol. 30, no. 2, pp. 55–60, 2006.

T. Iwamoto, N. Suzuki, K. Tanabe, T. Takeshita, and T. Hirofuji, “Effects of probiotic Lactobacillus salivarius WB21 on halitosis and oral health: an open-label pilot trial,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 110, no. 2, pp. 201–208, 2010.

N. Suzuki, K. Tanabe, T. Takeshita et al., “Effects of oil drops containing Lactobacillus salivarius WB21 on periodontal health and oral microbiota producing volatile sulfur compounds,” Journal of Breath Research, vol. 6, Article ID 017106, 7 pages, 2012.

H. Shimauchi, G. Mayanagi, S. Nakaya et al., “Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study,” Journal of Clinical Periodontology, vol. 35, no. 10, pp. 897–905, 2008.